Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Oct;35(10):2526–2530. doi: 10.1128/jcm.35.10.2526-2530.1997

Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?

J Rosenberg 1, F C Tenover 1, J Wong 1, W Jarvis 1, D J Vugia 1
PMCID: PMC230004  PMID: 9316901

Abstract

In order to determine whether hospital-based clinical laboratories conducting active surveillance for vancomycin-resistant enterococci in three San Francisco Bay area counties (San Francisco, Alameda, and Contra Costa counties) were accurately reporting vancomycin resistance, five vancomycin-resistant enterococcal strains and one vancomycin-susceptible beta-lactamase-producing enterococcus were sent to 31 of 32 (97%) laboratories conducting surveillance. Each strain was tested by the laboratory's routine antimicrobial susceptibility testing method. An Enterococcus faecium strain with high-level resistance to vancomycin (MIC, 512 microg/ml) was correctly reported as resistant by 100% of laboratories; an E. faecium strain with moderate-level resistance (MIC, 64 microg/ml) was correctly reported as resistant by 91% of laboratories; two Enterococcus faecalis strains with low-level resistance (MICs, 32 microg/ml) were correctly reported as resistant by 97 and 56% of laboratories, respectively. An Enterococcus gallinarum strain with intrinsic low-level resistance (MIC, 8 microg/ml) was correctly reported as intermediate by 50% of laboratories. A beta-lactamase-producing E. faecalis isolate was correctly identified as susceptible to vancomycin by 100% of laboratories and as resistant to penicillin and ampicillin by 68 and 44% of laboratories, respectively; all 23 (74%) laboratories that tested for beta-lactamase recognized that it was a beta-lactamase producer. This survey indicated that for clinically significant enterococcal isolates, laboratories in the San Francisco Bay area have problems in detecting low- to moderate-level but not high-level vancomycin resistance. Increasing accuracy of detection and prompt reporting of these isolates and investigation of cases are the next steps in the battle for control of the spread of vancomycin resistance.

Full Text

The Full Text of this article is available as a PDF (146.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyce J. M., Opal S. M., Chow J. W., Zervos M. J., Potter-Bynoe G., Sherman C. B., Romulo R. L., Fortna S., Medeiros A. A. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994 May;32(5):1148–1153. doi: 10.1128/jcm.32.5.1148-1153.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boyle J. F., Soumakis S. A., Rendo A., Herrington J. A., Gianarkis D. G., Thurberg B. E., Painter B. G. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993 May;31(5):1280–1285. doi: 10.1128/jcm.31.5.1280-1285.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Frieden T. R., Munsiff S. S., Low D. E., Willey B. M., Williams G., Faur Y., Eisner W., Warren S., Kreiswirth B. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993 Jul 10;342(8863):76–79. doi: 10.1016/0140-6736(93)91285-t. [DOI] [PubMed] [Google Scholar]
  4. Gaynes R. Surveillance of antibiotic resistance: learning to live with bias. Infect Control Hosp Epidemiol. 1995 Nov;16(11):623–626. doi: 10.1086/647025. [DOI] [PubMed] [Google Scholar]
  5. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K. V., Murray B. E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993 Jun;16(6):750–755. doi: 10.1093/clind/16.6.750. [DOI] [PubMed] [Google Scholar]
  6. Iwen P. C., Kelly D. M., Linder J., Hinrichs S. H. Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J Clin Microbiol. 1996 Jul;34(7):1779–1783. doi: 10.1128/jcm.34.7.1779-1783.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaplan A. H., Gilligan P. H., Facklam R. R. Recovery of resistant enterococci during vancomycin prophylaxis. J Clin Microbiol. 1988 Jun;26(6):1216–1218. doi: 10.1128/jcm.26.6.1216-1218.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Karanfil L. V., Murphy M., Josephson A., Gaynes R., Mandel L., Hill B. C., Swenson J. M. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992 Apr;13(4):195–200. doi: 10.1086/646509. [DOI] [PubMed] [Google Scholar]
  9. Krogstad D. J., Korfhagen T. R., Moellering R. C., Jr, Wennersten C., Swartz M. N. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism. J Clin Invest. 1978 Aug;62(2):480–486. doi: 10.1172/JCI109149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988 Jul 21;319(3):157–161. doi: 10.1056/NEJM198807213190307. [DOI] [PubMed] [Google Scholar]
  11. Lorian V. The need for surveillance for antimicrobial resistance. Infect Control Hosp Epidemiol. 1995 Nov;16(11):638–641. doi: 10.1086/647029. [DOI] [PubMed] [Google Scholar]
  12. Morris J. G., Jr, Shay D. K., Hebden J. N., McCarter R. J., Jr, Perdue B. E., Jarvis W., Johnson J. A., Dowling T. C., Polish L. B., Schwalbe R. S. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med. 1995 Aug 15;123(4):250–259. doi: 10.7326/0003-4819-123-4-199508150-00002. [DOI] [PubMed] [Google Scholar]
  13. Murray B. E. Can antibiotic resistance be controlled? N Engl J Med. 1994 Apr 28;330(17):1229–1230. doi: 10.1056/NEJM199404283301710. [DOI] [PubMed] [Google Scholar]
  14. Murray B. E., Mederski-Samaroj B. Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest. 1983 Sep;72(3):1168–1171. doi: 10.1172/JCI111042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murray B. E. The life and times of the Enterococcus. Clin Microbiol Rev. 1990 Jan;3(1):46–65. doi: 10.1128/cmr.3.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Osterholm M. T., MacDonald K. L. Antibiotic-resistant bugs: when, where, and why? Infect Control Hosp Epidemiol. 1995 Jul;16(7):382–384. doi: 10.1086/647134. [DOI] [PubMed] [Google Scholar]
  17. Paul S. M., Finelli L., Crane G. L., Spitalny K. C. A statewide surveillance system for antimicrobial-resistant bacteria: New Jersey. Infect Control Hosp Epidemiol. 1995 Jul;16(7):385–390. doi: 10.1086/647135. [DOI] [PubMed] [Google Scholar]
  18. Rubin L. G., Tucci V., Cercenado E., Eliopoulos G., Isenberg H. D. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol. 1992 Dec;13(12):700–705. doi: 10.1086/648342. [DOI] [PubMed] [Google Scholar]
  19. Sahm D. F., Olsen L. In vitro detection of enterococcal vancomycin resistance. Antimicrob Agents Chemother. 1990 Sep;34(9):1846–1848. doi: 10.1128/aac.34.9.1846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Swenson J. M., Clark N. C., Ferraro M. J., Sahm D. F., Doern G., Pfaller M. A., Reller L. B., Weinstein M. P., Zabransky R. J., Tenover F. C. Development of a standardized screening method for detection of vancomycin-resistant enterococci. J Clin Microbiol. 1994 Jul;32(7):1700–1704. doi: 10.1128/jcm.32.7.1700-1704.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tenover F. C., Swenson J. M., O'Hara C. M., Stocker S. A. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol. 1995 Jun;33(6):1524–1527. doi: 10.1128/jcm.33.6.1524-1527.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tenover F. C., Tokars J., Swenson J., Paul S., Spitalny K., Jarvis W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol. 1993 Jul;31(7):1695–1699. doi: 10.1128/jcm.31.7.1695-1699.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med. 1994 Apr 28;330(17):1247–1251. doi: 10.1056/NEJM199404283301725. [DOI] [PubMed] [Google Scholar]
  24. Walsh C. T. Vancomycin resistance: decoding the molecular logic. Science. 1993 Jul 16;261(5119):308–309. doi: 10.1126/science.8392747. [DOI] [PubMed] [Google Scholar]
  25. Wells C. L., Juni B. A., Cameron S. B., Mason K. R., Dunn D. L., Ferrieri P., Rhame F. S. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis. 1995 Jul;21(1):45–50. doi: 10.1093/clinids/21.1.45. [DOI] [PubMed] [Google Scholar]
  26. Willey B. M., Kreiswirth B. N., Simor A. E., Willaims G., Scriver S. R., Phillips A., Low D. E. Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol. 1992 Jul;30(7):1621–1624. doi: 10.1128/jcm.30.7.1621-1624.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Williamson R., le Bouguénec C., Gutmann L., Horaud T. One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J Gen Microbiol. 1985 Aug;131(8):1933–1940. doi: 10.1099/00221287-131-8-1933. [DOI] [PubMed] [Google Scholar]
  28. Woodford N., Johnson A. P., Morrison D., Speller D. C. Current perspectives on glycopeptide resistance. Clin Microbiol Rev. 1995 Oct;8(4):585–615. doi: 10.1128/cmr.8.4.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zabransky R. J., Di Nuzzo A. R., Huber M. B., Woods G. L. Detection of vancomycin resistance in enterococci by the Vitek AMS system. Diagn Microbiol Infect Dis. 1994 Oct;20(2):113–116. doi: 10.1016/0732-8893(94)90102-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES